Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
for Antiphospholipid Syndrome (APS)
Sites in Orange +6 more locations
Sponsor: Chugai Pharmaceutical
Sex: All·Age: 18 - 85
Code: NCT06371417·Phase 1·Recruiting·Listed Apr 2024
Paid Clinical Trials in California
California has 6,384 paid clinical trials enrolling now across cities including Los Angeles, San Francisco and San Diego. Search by condition, age, or phase to find compensated research studies accepting participants near you.
Research sites in California include Stanford Medicine, UCLA Health and UCSF, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
5,286 clinical trials
↓ Download CSVA Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
for Diffuse Large B-cell Lymphoma (DLBCL)
Drug: Odronextamab
Sites in Los Angeles, Sacramento +16 more locations
Sponsor: Regeneron Pharmaceuticals
Sex: All·Age: 18+
Code: NCT06091865·Phase 3·Recruiting·Listed Oct 2023
Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation
for Atrial Fibrillation (AF)
Sites in San Diego +17 more locations
Sponsor: Arga Medtech SA
Sex: All·Age: 18 - 80
Code: NCT06784466·Recruiting·Listed Jan 2025
Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used in Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) to Treat Aortoiliac Occlusive Disease
for Aortoiliac Occlusive Disease
Sites in Fresno +19 more locations
Sponsor: W.L.Gore & Associates
Sex: All·Age: 18 - 100
Code: NCT06872905·Recruiting·Listed Mar 2025
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
for Head and Neck Squamous Cell Carcinoma (HNSCC)
Drug: Cemiplimab
Sites in Los Angeles +13 more locations
Sponsor: Regeneron Pharmaceuticals
Sex: All·Age: 18+
Code: NCT06769698·Phase 2·Recruiting·Listed Jan 2025
A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia
for Autoimmune Haemolytic Anaemia
Sites in Los Angeles, Duarte +21 more locations
Sponsor: Sanofi
Sex: All·Age: 18+
Code: NCT07086976·Phase 3·Recruiting·Listed Jul 2025
Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
for Crohn's Disease
Drug: Upadacitinib
Sites in Palo Alto, Oakland +10 more locations
Sponsor: AbbVie
Sex: All·Age: 2 - 17
Code: NCT06332534·Phase 3·Recruiting·Listed Mar 2024
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
for Follicular Lymphoma (FL)
Drug: Odronextamab
Sites in Los Angeles +13 more locations
Sponsor: Regeneron Pharmaceuticals
Sex: All·Age: 18+
Code: NCT06091254·Phase 3·Recruiting·Listed Oct 2023
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
for Neutropenia
Sites in Los Angeles, La Jolla +20 more locations
Sponsor: X4 Pharmaceuticals
Sex: All·Age: 12+
Code: NCT06056297·Phase 3·Recruiting·Listed Sep 2023
A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer
for Metastatic Castration-resistant Prostate Cancer
Sites in Sacramento +22 more locations
Sponsor: Syncromune, Inc.
Sex: Male·Age: 18+
Code: NCT06533644·Phase 2·Recruiting·Listed Aug 2024
XTX301 in Patients With Advanced Solid Tumors
for Advanced Solid Tumor
Sites in Sacramento +9 more locations
Sponsor: Xilio Development, Inc.
Sex: All·Age: 18+
Code: NCT05684965·Phase 1, Phase 2·Recruiting·Listed Jan 2023
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
for Small Cell Lung Cancer (SCLC)
Sites in Los Angeles, Duarte +13 more locations
Sponsor: Phanes Therapeutics
Sex: All·Age: 18+
Code: NCT05652686·Phase 1, Phase 2·Recruiting·Listed Dec 2022
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
for Heart Failure
Sites in Los Angeles, Palo Alto +18 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 29 Days - 17
Code: NCT05714085·Phase 2, Phase 3·Recruiting·Listed Feb 2023
A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
for Alzheimer Disease
Drug: LY4006895
Sites in Los Alamitos +10 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 45 - 85·Accepts healthy volunteers
Code: NCT06657768·Phase 1·Recruiting·Listed Oct 2024
Study of XB010 in Subjects With Solid Tumors
for Locally Advanced or Metastatic Solid Tumors
Sites in Los Angeles, Irvine +14 more locations
Sponsor: Exelixis
Sex: All·Age: 18+
Code: NCT06545331·Phase 1·Recruiting·Listed Aug 2024
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
for Ovarian Cancer
Sites in Los Angeles, La Jolla +19 more locations
Sponsor: Regeneron Pharmaceuticals
Sex: Female·Age: 18+
Code: NCT06787612·Phase 2·Recruiting·Listed Jan 2025
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
for Ovarian Cancer
Sites in San Francisco, Palo Alto +15 more locations
Sponsor: Xencor, Inc.
Sex: All·Age: 15+
Code: NCT06276491·Phase 1·Recruiting·Listed Feb 2024
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
for Immune Thrombocytopenic Purpura (ITP)
Sites in Los Angeles +16 more locations
Sponsor: Takeda
Sex: All·Age: 18+
Code: NCT06722235·Phase 3·Recruiting·Listed Dec 2024
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
for Solid Tumor
Sites in Santa Monica +10 more locations
Sponsor: Astellas Pharma Inc
Sex: All·Age: 18+
Code: NCT07094204·Phase 1·Recruiting·Listed Jul 2025
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
for Advanced Solid Tumors
Sites in Duarte +8 more locations
Sponsor: Bayer
Sex: All·Age: 18+
Code: NCT06760819·Phase 2·Recruiting·Listed Jan 2025
A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)
for Duchenne Muscular Dystrophy
Sites in Los Angeles, San Diego +10 more locations
Sponsor: Solid Biosciences Inc.
Sex: Male·Age: 0 - 17
Code: NCT06138639·Phase 1, Phase 2·Recruiting·Listed Nov 2023
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
for Metastatic Castration-resistant Prostate Cancer
Sites in San Francisco +12 more locations
Sponsor: K36 Therapeutics, Inc.
Sex: Male·Age: 18+
Code: NCT07103018·Phase 1·Recruiting·Listed Aug 2025
A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
for Thrombocytopenia, Neonatal Alloimmune
Drug: Nipocalimab
Sites in Sacramento +11 more locations
Sponsor: Janssen Research & Development, LLC
Sex: Female·Age: 18 - 45
Code: NCT06533098·Phase 3·Recruiting·Listed Aug 2024
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
for Anemia, Sickle Cell
Sites in La Jolla, Oakland +16 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+·Accepts healthy volunteers
Code: NCT06481306·Phase 1, Phase 2·Recruiting·Listed Jul 2024
VTP-1000 in Adults With Celiac Disease
for Celiac Disease
Sites in Los Angeles +15 more locations
Sponsor: Barinthus Biotherapeutics
Sex: All·Age: 18 - 70
Code: NCT06310291·EARLY_Phase 1·Recruiting·Listed Mar 2024
An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as ANX005) in Participants With Guillain-Barré Syndrome (FORWARD Study)
for Guillain-Barre Syndrome
Sites in Orange, Carlsbad +10 more locations
Sponsor: Annexon, Inc.
Sex: All·Age: 12 - 85
Code: NCT07020819·Phase 3·Recruiting·Listed Jun 2025
DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
for Glioblastoma (GBM)
Sites in San Francisco, Duarte +15 more locations
Sponsor: Diakonos Oncology Corporation
Sex: All·Age: 18+
Code: NCT06805305·Phase 2·Recruiting·Listed Feb 2025
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
for Myasthenia Gravis
Sites in Los Angeles, Palo Alto +8 more locations
Sponsor: Kyverna Therapeutics
Sex: All·Age: 18 - 75
Code: NCT06193889·Phase 2, Phase 3·Recruiting·Listed Jan 2024
REVEAL: A Phase 3 Study of ION582 in Angelman Syndrome
for Angelman Syndrome
Sites in Los Angeles, San Diego +15 more locations
Sponsor: Ionis Pharmaceuticals, Inc.
Sex: All·Age: 2 - 50
Code: NCT06914609·Phase 3·Recruiting·Listed Apr 2025
Galvanize Prospective/Retrospective Pulsed Electric Field Device Registry
for Soft Tissue Lesion
Sites in Rancho Mirage +10 more locations
Sponsor: Galvanize Therapeutics, Inc.
Sex: All·Age: 18 - 100
Code: NCT05851430·Recruiting·Listed May 2023
The Pivotal Study of RapidPulseTM Aspiration System
for Acute Ischemic Stroke
Sites in Torrance +14 more locations
Sponsor: RapidPulse, Inc
Sex: All·Age: 18 - 80
Code: NCT06029491·Recruiting·Listed Sep 2023
A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
for Colorectal Cancer
Sites in Los Angeles +11 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06428409·Phase 1, Phase 2·Recruiting·Listed May 2024
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
for Acute Myeloid Leukemia
Sites in Sacramento, Duarte +6 more locations
Sponsor: Orca Biosystems, Inc.
Sex: All·Age: 12 - 78
Code: NCT03802695·Phase 1·Recruiting·Listed Jan 2019
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
for Multiple Myeloma
Drug: Elranatamab
Sites in Orange, Irvine +15 more locations
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT06057402·Phase 4·Recruiting·Listed Sep 2023
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
for Non-small Cell Lung Cancer
Drug: Calderasib
Sites in Beverly Hills, Bakersfield +11 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06345729·Phase 3·Recruiting·Listed Apr 2024
A Study of PHN-012 in Patients With Advanced Solid Tumors
for Colon Cancer
Sites in Los Angeles, San Diego +9 more locations
Sponsor: Pheon Therapeutics
Sex: All·Age: 18+
Code: NCT07127874·Phase 1·Recruiting·Listed Aug 2025
The Ailliance Post-Market Clinical Study
for Spinal Deformity
Sites in San Francisco, Sacramento +21 more locations
Sponsor: Medtronic Spinal and Biologics
Sex: All·Age: 18+
Code: NCT05856370·Recruiting·Listed May 2023
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
for Schizophrenia
Sites in San Diego, Orange +20 more locations
Sponsor: Neurocrine Biosciences
Sex: All·Age: 18+
Code: NCT07105111·Phase 4·Recruiting·Listed Aug 2025
A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors
for Solid Tumor
Sites in La Jolla +10 more locations
Sponsor: Genentech, Inc.
Sex: All·Age: 18+
Code: NCT06619587·Phase 1·Recruiting·Listed Oct 2024
TTVR Early Feasibility Study
for Tricuspid Regurgitation
Sites in Los Angeles, San Francisco +17 more locations
Sponsor: Medtronic Cardiovascular
Sex: All·Age: 18+
Code: NCT04433065·Recruiting·Listed Jun 2020